• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBeAg阴性慢性HBV感染中血清定量HBsAg、ALT与HBV DNA水平之间的关系。

Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.

作者信息

Günal Özgür, Barut Şener, Etikan İlker, Duygu Fazilet, Tuncel Umut, Sünbül Mustafa

机构信息

Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa Universtiy Faculty of Medicine, Tokat, Turkey.

出版信息

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:142-6. doi: 10.5152/tjg.2014.5711.

DOI:10.5152/tjg.2014.5711
PMID:25910293
Abstract

BACKGROUND/AIMS: In this study, we aimed to investigate whether quantitative HBsAg and alanine aminotransferase (ALT) levels correlated with Hepatitis B Virus (HBV) DNA levels in patients with HBeAg negative chronic HBV infection.

MATERIALS AND METHODS

Ninetynine patients were divided into two groups; inactive HBsAg carriers (IC) and active carriers (AC) with HBV DNA>2000 IU/mL. These two groups were compared in terms of ALT and HBsAg levels. Quantitative HBsAg measurements were performed with Elecsys HBsAg II Quant assay (Roche Diagnostic).

RESULTS

Mean age of patients was 43.11±14.79 years. HBsAg and ALT values of IC and AC patients were 2.47±1.35 log10 IU/mL, 3.59±0.97 log10 IU/mL (p=0.0001), and 25.94±13.06 IU/mL, 55.54±82.38 IU/mL (p=0.015), respectively and the difference was significant. When ROC analysis was performed to determine the most appropriate quantitative HBsAg value to define inactive carrier patients, the area under the ROC curve for HBsAg was 0.738 (95% CI:0.637-0.840). A cut-off of 2147 IU/mL revealed sensitivity of 76% and specificity of 70% for diagnosing the IC. Also, a significant correlation was also found between levels of HBV DNA (log) and HBsAg (log) (r: 0.503, p=0.0001).

CONCLUSION

It has been concluded that quantitative measurements of HBsAg could be used to differentiate between IC and AC patients.

摘要

背景/目的:在本研究中,我们旨在调查HBeAg阴性慢性乙型肝炎病毒(HBV)感染患者的HBsAg定量水平和丙氨酸氨基转移酶(ALT)水平是否与HBV DNA水平相关。

材料与方法

99例患者分为两组;HBsAg非活动携带者(IC)和HBV DNA>2000 IU/mL的活动携带者(AC)。比较这两组患者的ALT和HBsAg水平。使用Elecsys HBsAg II Quant检测法(罗氏诊断)进行HBsAg定量检测。

结果

患者的平均年龄为43.11±14.79岁。IC组和AC组患者的HBsAg值分别为2.47±1.35 log10 IU/mL、3.59±0.97 log10 IU/mL(p = 0.0001),ALT值分别为25.94±13.06 IU/mL、55.54±82.38 IU/mL(p = 0.015),差异具有统计学意义。在进行ROC分析以确定定义非活动携带者患者的最合适HBsAg定量值时,HBsAg的ROC曲线下面积为0.738(95%CI:0.637 - 0.840)。2147 IU/mL的临界值诊断IC的敏感性为76%,特异性为70%。此外,还发现HBV DNA(对数)水平与HBsAg(对数)水平之间存在显著相关性(r:0.503,p = 0.0001)。

结论

已得出结论,HBsAg定量检测可用于区分IC组和AC组患者。

相似文献

1
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.HBeAg阴性慢性HBV感染中血清定量HBsAg、ALT与HBV DNA水平之间的关系。
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:142-6. doi: 10.5152/tjg.2014.5711.
2
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.使用 HBsAg 和 HBV-DNA 的基线血清学测量预测无症状乙型肝炎 e 抗原阴性慢性乙型肝炎患者的疾病再激活。
J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.
3
[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].[乙肝表面抗原(HBsAg)水平能否用于区分非活动性HBsAg携带者与HBeAg阴性慢性乙型肝炎?]
Mikrobiyol Bul. 2007 Jan;41(1):87-93.
4
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.HBeAg 阴性慢性乙型肝炎病毒感染者的非活动和低病毒血症状态的长期结局:向 HBsAg 清除的良性过程。
Liver Int. 2017 Nov;37(11):1622-1631. doi: 10.1111/liv.13416. Epub 2017 Apr 18.
5
Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.HBsAg 定量对预测基因型 C HBeAg 阴性携带者的临床病程的价值。
Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30.
6
Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.乙型肝炎表面抗原(HBsAg)在鉴定感染 C 基因型乙型肝炎病毒的真正无活动 HBsAg 携带者中的作用。
J Clin Gastroenterol. 2014 Feb;48(2):166-71. doi: 10.1097/MCG.0b013e3182a4711d.
7
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.慢性乙型肝炎患儿血清乙型肝炎表面抗原和乙型肝炎e抗原定量水平的重要性。
Turk J Gastroenterol. 2015 Jan;26(1):36-41. doi: 10.5152/tjg.2015.4636.
8
Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.接受核苷/核苷酸类似物治疗的乙肝e抗原阴性慢性乙型肝炎患者严重再激活时的血清乙肝表面抗原动力学
Antivir Ther. 2013;18(8):979-86. doi: 10.3851/IMP2615. Epub 2013 Jun 6.
9
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.恩替卡韦治疗慢性乙型肝炎 2 年后患者的乙型肝炎表面抗原定量水平。
Am J Gastroenterol. 2011 Oct;106(10):1766-73. doi: 10.1038/ajg.2011.253. Epub 2011 Aug 9.
10
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.血清乙型肝炎表面抗原水平可预测乙型肝炎 e 抗原血清学转换者的表面抗原丢失。
Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.

引用本文的文献

1
Evaluation and Determination of Quantitative Hepatitis B Surface Antigen Diagnostic Performance in Chronic Hepatitis B Virus-Infected Patients.慢性乙型肝炎病毒感染患者中乙型肝炎表面抗原定量诊断性能的评估与测定
Cureus. 2023 Jun 30;15(6):e41202. doi: 10.7759/cureus.41202. eCollection 2023 Jun.
2
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.乙型肝炎病毒新型生物标志物及其在慢性乙型肝炎患者管理中的应用。
Viruses. 2021 May 21;13(6):951. doi: 10.3390/v13060951.
3
Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients.
定量乙肝表面抗原水平在预测初治慢性乙型肝炎患者肝活检时机中的作用。
Clin Exp Hepatol. 2020 Feb;6(1):55-59. doi: 10.5114/ceh.2020.93058. Epub 2020 Feb 17.